On Dec. 12, 2018, SOL Global Investments Corp. announced an investment in OG DNA Genetics Inc. ("DNA Genetics") in which  SOL Global acquired an approximate 8% stake for $13.3 million.

DNA Genetics is recognized worldwide for its highly selective, genetics-based approach to cannabis cultivation. DNA Genetics is established in the US cannabis marketplace, cooperating two million square feet of medical canopy in California, where they began developing high-quality cannabis seeds for the global market. DNA Genetics is also the exclusive provider of DNA certified products to a wholly-owned Ontario-based subsidiary which is of one of the world's largest diversified cannabis and hemp companies.

Gowling WLG was Canadian counsel to SOL Global in this investment with a team that included Peter Simeon and Josh Almario.